(Q39474556)

English

Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression

scientific article published on 14 September 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

0 references

pancreatic carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Peilin Cui

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Minghua Yu

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Xingchun Peng

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lv Dong

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Zhaoxu Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

14 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Journal of Pineal Research

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

236-243

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Mechanisms of cancer inhibition by melatonin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Angiogenesis inhibitors: current strategies and future prospects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Effects of melatonin on histomorphology and on the expression of steroid receptors, VEGF, and PCNA in ovaries of pinealectomized female rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Transcriptional anti-angiogenesis therapy of human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

VEGF as a key mediator of angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

A Review of the Multiple Actions of Melatonin on the Immune System

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

The effects of melatonin on angiogenesis and wound healing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Melatonin and cell death: differential actions on apoptosis in normal and cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

The immunoneuroendocrine role of melatonin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00933.X

21 January 2018

Identifiers

10.1111/J.1600-079X.2011.00933.X

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39474556&oldid=2150214829"